Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Comparison of clinical outcomes of patients with METDex14 NSCLC treated with first-line capmatinib in the GEOMETRY mono-1 study with those of a cohort of real-world patients Wolf, J., Neal, J. W., Mansfield, A. S., Doban, V., Kanakamedala, H., Wu, W., Joshi, A., de Jong, E., Giovannini, M., Baik, C. S. ELSEVIER. 2020: S863
View details for DOI 10.1016/j.annonc.2020.08.1660
View details for Web of Science ID 000573469101631